{"id":"https://openalex.org/W2298808807","doi":"https://doi.org/10.1111/1753-0407.12355","title":"Lower rates of hypoglycemia during maintenance treatment with insulin degludec/insulin aspart versus biphasic insulin aspart 30: a combined analysis of two Phase 3a studies in type 2 diabetes","display_name":"Lower rates of hypoglycemia during maintenance treatment with insulin degludec/insulin aspart versus biphasic insulin aspart 30: a combined analysis of two Phase 3a studies in type 2 diabetes","alternate_titles":[],"publication_year":2015,"publication_date":"2015-11-27","ids":{"openalex":"https://openalex.org/W2298808807","doi":"https://doi.org/10.1111/1753-0407.12355","mag":"2298808807","pmid":"https://pubmed.ncbi.nlm.nih.gov/26612062"},"language":"en","primary_location":{"id":"doi:10.1111/1753-0407.12355","doi":"https://doi.org/10.1111/1753-0407.12355","is_oa":true,"landing_page_url":"https://doi.org/10.1111/1753-0407.12355","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/1753-0407.12355","source":{"id":"https://openalex.org/S181994529","display_name":"Journal of Diabetes","issn_l":"1753-0407","issn":["1753-0407","1753-0393"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Diabetes","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2298808807"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/1753-0407.12355","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5066686056","display_name":"Jens Sandahl Christiansen","orcid":"https://orcid.org/0000-0002-2831-3645","observed_orcids":["https://orcid.org/0000-0002-2831-3645"]},"institutions":[{"id":"https://openalex.org/I2802335433","display_name":"Aarhus University Hospital","ror":"https://ror.org/040r8fr65","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2802335433"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Jens Sandahl Christiansen","raw_affiliation_strings":["Aarhus University Hospital, Aarhus"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aarhus University Hospital, Aarhus","institution_ids":["https://openalex.org/I2802335433"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048168425","display_name":"LEO K. NISKANEN","orcid":"https://orcid.org/0000-0003-1503-7060","observed_orcids":["https://orcid.org/0000-0003-1503-7060"]},"institutions":[{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]},{"id":"https://openalex.org/I2800394112","display_name":"Helsinki University Hospital","ror":"https://ror.org/02e8hzf44","country_code":"FI","type":"healthcare","lineage":["https://openalex.org/I2800394112","https://openalex.org/I4210166427"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Leo Niskanen","raw_affiliation_strings":["Helsinki University Hospital and University of Helsinki, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Helsinki University Hospital and University of Helsinki, Helsinki, Finland","institution_ids":["https://openalex.org/I133731052","https://openalex.org/I2800394112"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019715513","display_name":"S\u00f8ren Rasmussen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"S\u00f8ren Rasmussen","raw_affiliation_strings":["Novo Nordisk A/S  S\u00f8borg Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novo Nordisk A/S  S\u00f8borg Denmark","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033894744","display_name":"Thue Johansen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Thue Johansen","raw_affiliation_strings":["Novo Nordisk A/S  S\u00f8borg Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novo Nordisk A/S  S\u00f8borg Denmark","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109417005","display_name":"Greg Fulcher","orcid":"https://orcid.org/0000-0001-8782-0420","observed_orcids":["https://orcid.org/0000-0001-8782-0420"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]},{"id":"https://openalex.org/I2800079252","display_name":"Royal North Shore Hospital","ror":"https://ror.org/02gs2e959","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800079252"]}],"countries":["AU"],"is_corresponding":true,"raw_author_name":"Greg Fulcher","raw_affiliation_strings":["University of Sydney, Royal North Shore Hospital, Sydney, New South Wales, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Sydney, Royal North Shore Hospital, Sydney, New South Wales, Australia","institution_ids":["https://openalex.org/I129604602","https://openalex.org/I2800079252"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5109417005"],"corresponding_institution_ids":["https://openalex.org/I129604602","https://openalex.org/I2800079252"],"apc_list":{"value":3000,"currency":"USD","value_usd":3000},"apc_paid":{"value":3000,"currency":"USD","value_usd":3000},"fwci":2.787,"has_fulltext":true,"cited_by_count":29,"citation_normalized_percentile":{"value":0.90335144,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"8","issue":"5","first_page":"720","last_page":"728"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.8378999829292297,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.8378999829292297,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.1574999988079071,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/insulin-degludec-insulin-aspart","display_name":"IDegAsp","score":0.9769999980926514},{"id":"https://openalex.org/keywords/biphasic-insulin-aspart-30","display_name":"biphasic insulin aspart 30","score":0.9929999709129333},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.9599999785423279},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9649999737739563},{"id":"https://openalex.org/keywords/multiple-daily-injections","display_name":"multiple daily insulin injections","score":0.7289999723434448},{"id":"https://openalex.org/keywords/nocturnal-hypoglycemia","display_name":"nocturnal hypoglycemia","score":0.902999997138977},{"id":"https://openalex.org/keywords/severe-hypoglycemia","display_name":"severe hypoglycemia","score":0.9620000123977661},{"id":"https://openalex.org/keywords/insulin-degludec","display_name":"insulin degludec","score":0.6660000085830688},{"id":"https://openalex.org/keywords/insulin-aspart","display_name":"insulin aspart","score":0.9520000219345093},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.421999990940094},{"id":"https://openalex.org/keywords/treat-to-target","display_name":"treat-to-target","score":0.7480000257492065},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.6190000176429749},{"id":"https://openalex.org/keywords/hypoglycemia-risk","display_name":"hypoglycemia risk","score":0.6349999904632568}],"concepts":[{"id":"https://openalex.org/C2779908123","wikidata":"https://www.wikidata.org/wiki/Q2754775","display_name":"Insulin aspart","level":4,"score":0.9175868034362793},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9158357977867126},{"id":"https://openalex.org/C2775927303","wikidata":"https://www.wikidata.org/wiki/Q16252338","display_name":"Insulin degludec","level":5,"score":0.8941028714179993},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.7057483792304993},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6895708441734314},{"id":"https://openalex.org/C2780668416","wikidata":"https://www.wikidata.org/wiki/Q202758","display_name":"Hypoglycemia","level":3,"score":0.6790708303451538},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.6336245536804199},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5610041618347168},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.510118305683136},{"id":"https://openalex.org/C2781232474","wikidata":"https://www.wikidata.org/wiki/Q124407","display_name":"Type 1 diabetes","level":3,"score":0.4553215801715851},{"id":"https://openalex.org/C2779920387","wikidata":"https://www.wikidata.org/wiki/Q417317","display_name":"Insulin glargine","level":4,"score":0.22413307428359985}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007003","descriptor_name":"Hypoglycemia","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D007003","descriptor_name":"Hypoglycemia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D007336","descriptor_name":"Insulin, Isophane","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007336","descriptor_name":"Insulin, Isophane","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015337","descriptor_name":"Multicenter Studies as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017063","descriptor_name":"Outcome Assessment, Health Care","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D017063","descriptor_name":"Outcome Assessment, Health Care","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D017326","descriptor_name":"Clinical Trials, Phase III as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D049528","descriptor_name":"Insulin, Long-Acting","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D049528","descriptor_name":"Insulin, Long-Acting","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D060046","descriptor_name":"Maintenance Chemotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061265","descriptor_name":"Biphasic Insulins","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D061265","descriptor_name":"Biphasic Insulins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D061267","descriptor_name":"Insulin Aspart","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D061267","descriptor_name":"Insulin Aspart","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1111/1753-0407.12355","doi":"https://doi.org/10.1111/1753-0407.12355","is_oa":true,"landing_page_url":"https://doi.org/10.1111/1753-0407.12355","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/1753-0407.12355","source":{"id":"https://openalex.org/S181994529","display_name":"Journal of Diabetes","issn_l":"1753-0407","issn":["1753-0407","1753-0393"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Diabetes","raw_type":"journal-article"},{"id":"pmid:26612062","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26612062","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of diabetes","raw_type":"Journal Article"},{"id":"pmh:oai:helda.helsinki.fi:10138/167945","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10138/167945","pdf_url":null,"source":{"id":"https://openalex.org/S4406922691","display_name":"Helda - University of Helsinki Institutional Repository","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Article"},{"id":"pmh:oai:pure.atira.dk:openaire/c2991ef6-9aa4-4ef1-875a-ff1314ec7e69","doi":null,"is_oa":true,"landing_page_url":"https://pure.au.dk/portal/en/publications/c2991ef6-9aa4-4ef1-875a-ff1314ec7e69","pdf_url":null,"source":null,"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Christiansen, J S, Niskanen, L, Rasmussen, S, Johansen, T & Fulcher, G 2016, 'Lower rates of hypoglycemia during maintenance treatment with IDegAsp versus BIAsp 30: a combined analysis of two phase 3a studies in type 2 diabetes', Journal of Diabetes, vol. 8, no. 5, pp. 720-8. https://doi.org/10.1111/1753-0407.12355","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1111/1753-0407.12355","doi":"https://doi.org/10.1111/1753-0407.12355","is_oa":true,"landing_page_url":"https://doi.org/10.1111/1753-0407.12355","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/1753-0407.12355","source":{"id":"https://openalex.org/S181994529","display_name":"Journal of Diabetes","issn_l":"1753-0407","issn":["1753-0407","1753-0393"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Diabetes","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320322436","display_name":"Novo Nordisk","ror":"https://ror.org/0435rc536"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2298808807.pdf","grobid_xml":"https://content.openalex.org/works/W2298808807.grobid-xml"},"referenced_works_count":21,"referenced_works":["https://openalex.org/W1565099151","https://openalex.org/W1613501644","https://openalex.org/W1658549429","https://openalex.org/W2022069934","https://openalex.org/W2029761237","https://openalex.org/W2031178950","https://openalex.org/W2034327086","https://openalex.org/W2035760642","https://openalex.org/W2042767418","https://openalex.org/W2046175880","https://openalex.org/W2047383351","https://openalex.org/W2057595002","https://openalex.org/W2117304511","https://openalex.org/W2126375001","https://openalex.org/W2128395400","https://openalex.org/W2140672693","https://openalex.org/W2145583809","https://openalex.org/W2147241398","https://openalex.org/W2160088494","https://openalex.org/W2166393441","https://openalex.org/W2318142092"],"related_works":["https://openalex.org/W2512144403","https://openalex.org/W2337646370","https://openalex.org/W2169664985","https://openalex.org/W2166393441","https://openalex.org/W2035760642","https://openalex.org/W4391988573","https://openalex.org/W2332567887","https://openalex.org/W1871019915","https://openalex.org/W2901955691","https://openalex.org/W2532403559"],"abstract_inverted_index":{"BACKGROUND:":[0],"Insulin":[1],"degludec/insulin":[2],"aspart":[3,20,49],"(IDegAsp)":[4],"is":[5],"a":[6,22,233],"soluble":[7],"coformulation":[8],"of":[9,29,37,70,100,175,236],"the":[10,16,35,98,165],"basal":[11],"analog":[12],"insulin":[13,19,48],"degludec":[14],"and":[15,89,105,112,149,180,205],"rapid-acting":[17],"prandial":[18],"in":[21,39,229,241],"single":[23],"injection.":[24],"The":[25,158],"present":[26],"combined":[27],"analysis":[28],"two":[30,59],"Phase":[31,66],"3a":[32,67],"trials":[33,69],"compared":[34,170],"incidence":[36],"hypoglycemia":[38],"participants":[40],"treated":[41,79,246],"twice":[42,80,221,224],"daily":[43,81,225],"with":[44,72,82,87,116,171,184,218,232,243,247],"IDegAsp":[45,83,117,185,223],"or":[46,84],"biphasic":[47],"30":[50,123,220],"(BIAsp":[51],"30).":[52],"METHODS:":[53],"Hypoglycemia":[54],"data":[55],"were":[56,78,109,130,161,186],"analyzed":[57],"from":[58],"similarly":[60],"designed":[61],"randomized":[62],"controlled":[63],"open-label":[64],"treat-to-target":[65],"clinical":[68],"adults":[71],"type":[73],"2":[74],"diabetes":[75],"(T2D).":[76],"Participants":[77],"BIAsp":[85,122,172,219],"30,":[86,173],"breakfast":[88],"their":[90],"main":[91],"evening":[92],"meal.":[93],"RESULTS:":[94],"Over":[95],"26":[96],"weeks,":[97],"rates":[99,174],"overall":[101,176],"confirmed,":[102,177],"nocturnal":[103,178,239],"confirmed":[104,179],"severe":[106,181],"hypoglycemic":[107,182],"events":[108,183],"19%,":[110],"57%,":[111],"39%":[113],"lower,":[114],"respectively,":[115],"(n":[118,124],"=":[119,125,139,147,156,194,213],"504)":[120],"than":[121],"364);":[126],"estimated":[127],"rate":[128],"ratios":[129],"0.81":[131],"(95%":[132,142,151,188,197,207],"confidence":[133],"interval":[134],"[CI]":[135],"0.67,":[136],"0.98;":[137],"P":[138,146,155,193,202,212],"0.0341),":[140],"0.43":[141],"CI":[143,152,189,198,208],"0.31,":[144],"0.59;":[145,210],"0.0001),":[148,204],"0.61":[150],"0.26,":[153],"1.45;":[154],"NS).":[157],"between-treatment":[159],"differences":[160],"more":[162],"pronounced":[163],"during":[164],"maintenance":[166],"period":[167],"(\u226516":[168],"weeks);":[169],"0.69":[187],"0.55,":[190],"0.87;":[191],"-31%;":[192],"0.0015);":[195],"0.38":[196],"0.25,":[199],"0.58;":[200],"-62%;":[201],"<":[203],"0.16":[206],"0.04,":[209],"-84%;":[211],"0.0061),":[214],"respectively.":[215],"CONCLUSIONS:":[216],"Compared":[217],"daily,":[222],"provided":[226],"similar":[227],"improvements":[228],"glycemic":[230],"control":[231],"lower":[234],"risk":[235],"hypoglycemia,":[237,240],"particularly":[238],"subjects":[242],"T2D":[244],"previously":[245],"insulin.":[248]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2298808807","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":7}],"updated_date":"2026-11-19T14:11:59.513116","created_date":"2016-06-24T00:00:00"}
